dc.contributor.author | Rashtchizadeh, N | |
dc.contributor.author | Karimi, P | |
dc.contributor.author | Dehgan, P | |
dc.contributor.author | Salimi Movahed, M | |
dc.date.accessioned | 2018-08-26T05:41:44Z | |
dc.date.available | 2018-08-26T05:41:44Z | |
dc.date.issued | 2015 | |
dc.identifier | 10.15171/jcvtr.2015.23 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/40539 | |
dc.description.abstract | This study aimed to discover by which mechanism selenium (Se) suppresses stimulated platelets stimulation in oxidative stress underlying diseases.Human platelets pretreated with Se and stimulated by Cu(2+)-oxidized low density of lipoprotein (OxLDL) or thrombin before assessment of P-selectin and phosphorylated p38 mitogen-activated protein kinase (p-p38MAPK), phosphorylated Jun N-terminal kinase (p- JNK), and phosphorylated extracellular signal-regulated kinases (p-ERK1/2). All variables were measured by solid phase sandwich enzyme-linked immunosorbent assay (ELISA).Se significantly decreased Cu(2+)-OxLDL induced P-selectin expression, as well as p38 and JNK phosphorylation in platelets, but could not significantly reduce ERK1/2 phosphorylation.Se suppresses inflamed platelets. This effect maybe partly mediated by the p38 or c-JNK signaling pathways. These results create possibility of new co-anti-inflammatory insight for Se in atherosclerosis. | |
dc.language.iso | English | |
dc.relation.ispartof | Journal of cardiovascular and thoracic research | |
dc.title | Effects of Selenium in the MAPK Signaling Cascade. | |
dc.type | article | |
dc.citation.volume | 7 | |
dc.citation.issue | 3 | |
dc.citation.spage | 107 | |
dc.citation.epage | 12 | |
dc.citation.index | Pubmed | |
dc.identifier.DOI | https://doi.org/10.15171/jcvtr.2015.23 | |